# Silo Pharma, Inc.: Form 8-K, filed Jul 13, 2026

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2026-07-13
- Accepted by EDGAR: Jul 10, 2026, 22:29 ET
- Period: 2026-07-09
- Accession: 0001213900-26-077296
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/ea0297602-8k_silo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/ea0297602-8k_silo.htm

Filed Jul 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-077296. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.